Featured
Collaborative project between Myers lab and Epicentre featured in Genome Research
News Outlet:
Genome Research
Date published:
December 1, 2011
Download PDF:
A collaborative effort between Epicentre and the HudsonAlpha Institute for Biotechnology resulted in the development of two novel transposon-based methods for RNA-Seq library preparation. The technique, called Tn-RNA-Seq, can use double-stranded cDNA created from rRNA-depleted RNA to prepare an Illumina sequencing library using only two enzymatic reactions. The researchers generated high-quality RNA-Seq libraries from as little as 10 pg of mRNA (~1 ng of total RNA) with this approach.
To read the rest of the article, click here.
Tie the Ribbons luncheon brings awareness to breast and ovarian cancers
News Outlet:
The Huntsville Times
Date published:
October 21, 2011 Dr. Debra Moriarity knew about breast cancer before it knew about her.
As a member of the biology faculty at the University of Alabama in Huntsville, Moriarity studied breast cancer and had long decided that, with the knowledge she had gained, she wouldn't hesitate to undergo a double mastectomy should the cancer ever find her.
And when it did in 2005, Moriarity said "it was odd" being a victim of the disease she had studied.
UAB Reporter highlights HudsonAlpha's partnership with graduate students
News Outlet:
UAB Reporter
Date published:
October 13, 2011 A new partnership between the Genetics and Genomic Sciences (GGS) Graduate Program and research juggernaut HudsonAlpha Institute for Biotechnology in Huntsville will substantially increase UAB’s expertise and exposure in the area of genomics and give students the opportunity to engage in large-scale genomic analyses.
HudsonAlpha researchers demonstrate sporadic mutations may be responsible for half of schizophrenia cases
HUNTSVILLE, Ala. - Although it affects less than 1 percent of the global population, schizophrenia exacts a large toll in terms of expense and human suffering. A new study from researchers at the HudsonAlpha Institute for Biotechnology, with colleagues from Columbia University in New York and the University of Pretoria in South Africa, indicate non-familial genetic mutations may account for about half of schizophrenia cases.
